Tag: POSEIDON

POSEIDON: Novel option for harder-to-treat subgroups of patients with metastatic NSCLC?

Presented By
Prof. Solange Peters, Lausanne University, Switzerland
Trial
Phase 3, POSEIDON
Conference
WCLC 2022
Type
News article

23 August 2022 10:47

Immunotherapy delays deterioration in health-related quality of life in metastatic NSCLC

Presented By
Dr Edward Garon, David Geffen School of Medicine at UCLA, CA, USA
Trial
Phase 3, POSEIDON
Conference
ELCC 2022
Type
Peer-reviewed article

25 May 2022 12:36

ELCC 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ELCC 2022

19 April 2022 10:43
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com